isoproterenol has been researched along with arbutin in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Alavala, S; Jerald, MK; Mir, SM; Nalban, N; Sangaraju, R; Sistla, R | 1 |
| Asaikumar, L; Sivasangari, S; Vennila, L | 1 |
2 other study(ies) available for isoproterenol and arbutin
| Article | Year |
|---|---|
Arbutin Attenuates Isoproterenol-Induced Cardiac Hypertrophy by Inhibiting TLR-4/NF-κB Pathway in Mice.
Topics: Animals; Anti-Inflammatory Agents; Antioxidants; Arbutin; Atrial Natriuretic Factor; Cardiomegaly; Cardiotoxicity; Disease Models, Animal; Interleukin-6; Isoproterenol; Male; Mice, Inbred C57BL; Myocytes, Cardiac; Natriuretic Peptide, Brain; NF-kappa B; Oxidative Stress; Signal Transduction; Toll-Like Receptor 4; Tumor Necrosis Factor-alpha; Ventricular Remodeling | 2020 |
Arbutin prevents alterations in mitochondrial and lysosomal enzymes in isoproterenol-induced myocardial infarction: An in vivo study.
Topics: Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Arbutin; Cathepsin B; Heart; Isoproterenol; Lysosomes; Male; Mitochondria, Heart; Myocardial Infarction; Protective Agents; Rats; Rats, Wistar; Thiobarbituric Acid Reactive Substances | 2021 |